TP53 and medulloblastoma: This same observation on SHH outcome, also independent of TP53 mutation, was reported by the Hospital for Sick Children, Toronto, Canada (Sickkids) group in 2 papers2,29 and by the widest randomized study in high-risk medulloblastoma so far reported by the Children’s Oncology Group ACNS0332 Study.15